Abu Dhabi Hosts the 4th Forum for Promoting Peace in Muslim Societies
The UAE hosted the 4th Forum for Promoting Peace in Muslim Societies during 11-13 December 2017, under the Patronage of HH Sheikh Abdullah bin Zayed Al Nahyan, Minister of Foreign Affairs and International Cooperation. Under the theme ‘Global Peace and the Fear of Islam: Countering the Spread of Extremism’, the ground-breaking event founded by H.E Shaykh Abdallah Bin Bayyah, President of the Forum, was held at St. Regis Hotel, Abu Dhabi Corniche, and attended by high-level officials and an elite group of scholars, intellectuals and religious leaders of different faiths.
This press release features multimedia. View the full release here: http://www.businesswire.com/news/home/20171220006231/en/
H.E Shaykh Abdallah bin Bayyah President of the Forum for Promoting Peace in Muslim Societies (Photo: AETOSWire)
The Forum discussed four main topics namely; Religion, Identity and World Peace; Islam and the World; Islam and the World: Ways to Rapprochement and Solidarity; and Fear of Islam: Causes and Contexts.
The opening session included keynote speeches by H.E Sheikh Nahyan bin Mubarak Al Nahyan, Minister of Tolerance; H.E Dr. Mohammed bin Abdul Karim Al Issa, Secretary General of the Muslim World League; Dr. Ahmed Tawfiq, Moroccan Minister of Endowments and Islamic Affairs; H.E Dr. Abbas Shoman, Deputy of Al-Azhar Al-Sharif; Dr. Lukman Hakim Saifuddin, Indonesian Minister of Islamic Affairs; HE Dr. Sardar Mohammad Yusuf, Minister for Religious Affairs in Pakistan; H.E Adama Dieng, UN Special Adviser on the Prevention of Genocide; and H.E Dr. Mohammed Matar Al Kaabi, the Forum’s Secretary General, Chairman of the General Authority for Islamic Affairs and Endowments.
The opening session’s key highlight was the joint cooperation agreement announced between the United Nations, represented by Undersecretary-General Adama Dieng, United Nations Special Adviser on the Prevention of Genocide, and the Forum for Promoting Peace in Muslim Societies, to organize ten research workshops to promote religious education in the Islamic world.
Day one sessions tackled the ‘International Climate for World Peace’, moderated by Mohammed Al Hammadi, Editor-in-Chief of Al-Ittihad Newspaper, and ‘Religion, Identity and Violence’, moderated by Dr. Abdulla Matouq Matouq, CEO of the International Islamic Charitable Organization.
Topics of the second day included ‘An Islamic Vision for World Peace’, moderated by H.E Dr. Mohammed Mokhtar Juma, Egypt’s Awqaf Minister; ‘Islam and the World: Ways to Rapprochement and Solidarity’, by H.E Faisal Bin Abdulrahman Bin Muaammar, Secretary-General, (KAICIID); and ‘Fear of Islam: Causes and Contexts’, by Dr. Mohamed Senoussi, member of the Board of Trustees of the Forum.
A gala dinner was organized on the second day to honor the Egyptian Family House organization, winner of the Imam Al Hassan bin Ali Award 2017, presented to Dr. Mahmoud Hamdi Zaqzouq, Secretary General of the organization; and His Eminence Anba Ermia, General Bishop and head of the Coptic Orthodox Cultural Center, Assistant Secretary General.
Eight workshops took place on the third day and discussed several themes, such as ‘Today’s Islamophobia’; Fear of Islam: From a Western Perspective; and ‘Jihad, from Fighting to an interconnection effort’; to name a few.
H.E Shaykh bin Bayyah and H.E Dr. Al Kaabi attended the final session, during which the Final Communiqué was announced.
To read more news releases about the Fourth Annual Forum for Promoting Peace in Muslim Societies, please follow this link: http://aetoswire.com//newsroom/1/forum-for-promoting-peace-in-muslim-societies
*Source: AETOS Wire
Forum for Promoting Peace in Muslim Societies
Amani Mohamad, Media Office, +971503366878
Om Business Wire
(c) 2018 Business Wire, Inc., All rights reserved.
Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.
Følg saker fra Business Wire
Registrer deg med din epostadresse under for å få de nyeste sakene fra Business Wire på epost fortløpende. Du kan melde deg av når som helst.
Siste saker fra Business Wire
ERYTECH Announces Filing of 2017 “Document de Référence” and 2017 Annual Report on Form 20-F24.4.2018 20:30 | Pressemelding
Regulatory News: ERYTECH Pharma (Euronext Paris: ERYP – Nasdaq: ERYP), the clinical-stage biopharmaceutical company developing innovative therapies for severe forms of cancer and orphan diseases based on its proprietary ERYCAPS platform, encapsulating therapeutic drug substances inside red blood cells, today announced that it had filed its 2017 “Document de Référence” for the year ended December 31, 2017, including the management report and the annual financial report with the “Autorité des Marchés Financiers (AMF)” and its Annual Report on Form 20-F for the year ended December 31, 2017 with the U.S. Securities and Exchange Commission (SEC). These documents can be accessed on the Investors section of the Company’s corporate website (www.erytech.com). In addition, the “Document de Référence” is also available on the AMF’s website (http://www.amf-france.org) and the Annual Report on Form 20-F is also available on the SEC’s website (www.sec.gov). Printed copies of these documents are also
Rimini Street Launches New Solutions that Further Extend the Life and Value of Enterprise Software as a Foundation for Innovation24.4.2018 16:00 | Pressemelding
Rimini Street, Inc . (Nasdaq: RMNI), a global provider of enterprise software products and services, and the leading third-party support provider for Oracle and SAP software products, today announced the first offerings in a family of solutions designed to provide improved competitive advantage to organizations with mature and valuable enterprise software investments that can be used as a foundation for innovation. Rimini Street’s new solutions can enable an organization to quickly and cost-effectively modernize their current enterprise software with the latest desired features and capabilities, future-proof their technical platforms against yet-unknown technology changes, and secure their systems against a constantly evolving threat environment. Rimini Street’s new solutions enable organizations to leverage their existing systems as a solid foundation for an innovative hybrid IT strategy. This press release features multimedia. View the full release here: https://www.businesswire.com/
Novaliq to Present Scientific and Clinical Research During the 2018 Association for Research in Vision and Ophthalmology Meeting in Honolulu, HI24.4.2018 15:53 | Pressemelding
Novaliq GmbH, a specialty pharmaceutical company with a disruptive drug delivery platform that transforms poorly soluble drugs into effective therapeutics for ophthalmology, today announced that four scientific posters will be presented at the 2018 Association for Research in Vision and Ophthalmology (ARVO) Meeting in Honolulu, HI (April 29-May 3). The variety of data to be presented reflects Novaliq’s dedication to science and clinical research. With the collection of posters, Novaliq will share clinical and pre-clinical data on its EyeSol® drug delivery technology and provide insights into the mode of action of its NOV03/NovaTears® water-free therapy for the treatment of dry eye disease (DED). Furthermore, Novaliq will present its first pre-clinical efficacy data in glaucoma. Scientific posters supported by Novaliq will include: “Influence of perfluorohexyloctane containing eye drops on tear film thickness in patients with mild to moderate dry eye disease.” Authors: Garhöfer G., Schm
Temasys Communications and Appian Partner to Power Real-Time Communications in the Contact Center24.4.2018 15:00 | Pressemelding
Temasys Communications announced today that Appian has integrated with the Temasys Skylink technology, enabling real-time communications, including chat and co-browsing, in Appian’s new Intelligent Contact Center (ICC) Platform. “For our contact center customers, omni-channel communications are essential. Appian is working with Temasys to provide contact centers with real-time communication channels such as chat and co-browsing via the Temasys versatile SDKs,” said Arturo Oliver, Senior Director of Product Strategy at Appian. Temasys Skylink APIs will be compatible with the Appian Intelligent Contact Center Platform, making it easy for Appian customers to add real-time communication to their applications, including chat, voice, video and co-browsing. These integrations enable users to visit a website, begin a chat session that seamlessly escalates to a voice call and extend to co-browsing — all without changing apps or establishing a new connection. “We’re thrilled to work with Appian
PPG Reports Sustainability Progress, New 2025 Goals24.4.2018 13:07 | Pressemelding
PPG (NYSE:PPG) today released its 2017 Corporate Sustainability Report, which details the company’s continued progress in strengthening its sustainable operations in 2017 and the launch of new, aggressive sustainability goals it aims to achieve by 2025. The report is available at sustainability.ppg.com. “PPG’s sustainability efforts go beyond product innovations to extend to our customers’ operations and the communities in which we operate,” said Mark Cancilla, PPG vice president, environment, health and safety. “We are encouraged by our progress in 2017 and excited about our new goals, which are representative of the challenges and opportunities of our current business portfolio.” The company achieved the following progress in 2017: 32 percent of sales from products that provide customers with a sustainable advantage, an increase of 60 percent since 2012. This includes the unveiling of multiple products that provide a sustainable solution, such as Sigma Air Pure, a revolutionary bio-b
Bioiberica Approves Its Combined Drug for Osteoarthritis in Five More European Countries24.4.2018 12:17 | Pressemelding
Bioiberica's combination of chondroitin sulphate and glucosamine hydrochloride, a slow action drug to treat osteoarthritis symptoms, was approved as an ethical drug in France, Austria, Hungary, Poland, and Finland through a mutual recognition process from Spain. ‘This approval confirms that Drug Agencies from different countries attest to the effectiveness and safety of the combination of pharmaceutical grade chondroitin sulphate and glucosamine hydrochloride. This drug has proven to reduce pain and improve mobility in people affected by knee osteoarthritis which, due to its safety profile, could also be used as an alternative by those patients with cardiovascular or gastrointestinal problems who should not be prescribed anti-inflammatory drugs chronically’, stated Dr Juan Gispert, Bioiberica's R&D director. The principle study that guarantees its effectiveness is the MOVES clinical trial, published in the Annals of the Rheumatic Diseases, which concludes that the combination of chondr